期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Current and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease 被引量:10
1
作者 I Jane Cox Amar Sharif +2 位作者 jeremy fl cobbold Howard C Thomas Simon D Taylor-Robinson 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第30期4773-4783,共11页
Nuclear magnetic resonance spectroscopy allows the study of cellular biochemistry and metabolism, both in the whole body in vivo and at higher magnetic field strengths in vitro. Since the technique is non-invasive and... Nuclear magnetic resonance spectroscopy allows the study of cellular biochemistry and metabolism, both in the whole body in vivo and at higher magnetic field strengths in vitro. Since the technique is non-invasive and non-selective, magnetic resonance spectroscopy methodologies have been widely applied in biochemistry and medicine. In vitro magnetic resonance spectroscopy studies of cells, body fluids and tissues have been used in medical biochemistry to investigate pathophysiologi- cal processes and more recently, the technique has been used by physicians to determine disease abnormalities in vivo. This highlighted topic illustrates the potential of in vitro magnetic resonance spectroscopy in studying the hepatobiliary system. The role of in vitro proton and phosphorus magnetic resonance spectroscopy in the study of malignant and non-malignant liver disease and bile composition studies are discussed, particularly with reference to correlative in vivo whole-body magnetic resonance spectroscopy applications. In summary, magnetic resonance spectroscopy techniques can provide non-invasive biochemical information on disease severity and pointers to underlying pathophysiological processes. Magnetic resonance spectroscopy holds potential promise as a screening tool for disease biomarkers, as well as assessing therapeutic response. 展开更多
关键词 Magnetic resonance spectroscopy LIVER Hepatobiliary disease Membrane metabolism
下载PDF
Role of microbubble ultrasound contrast agents in the non-invasive assessment of chronic hepatitis C-related liver disease 被引量:2
2
作者 Scott Grier Adrian KP Lim +4 位作者 Nayna Patel jeremy fl cobbold Howard C Thomas Isobel J Cox Simon D Taylor-Robinson 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第22期3461-3465,共5页
Patients who are chronically infected with the hepatitis C virus often develop chronic liver disease and assessment of the severity of liver injury is required prior to considering viral eradication therapy. This arti... Patients who are chronically infected with the hepatitis C virus often develop chronic liver disease and assessment of the severity of liver injury is required prior to considering viral eradication therapy. This article examines the various assessment methods currently available from gold standard liver biopsy to serological markers and imaging. Ultrasound is one of the most widely used imaging modalities in clinical practice and is already a first-line diagnostic tool for liver disease. Microbubble ultrasound contrast agents allow higher resolution images to be obtained and functional assessments of microvascular change to be carried out. The role of these agents in quantifying the state of hepatic injury is discussed as a viable method of determining the stage and grade of liver disease in patients with hepatitis C. Although currently confined to specialist centres, the availability of microbubble contrast-enhanced ultrasound will inevitably increase in the clinical setting. 展开更多
关键词 Hepatitis C Microbubble contrast agents ULTRASOUND
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部